D Fibroheal and its range is a flagship product made from silk proteins to heal different types of acute and chronic wounds. This is also towards the “AtmaNirbhar Push” and “Using local and making global range of products”.
Fibroheal Woundcare Pvt ltd is a medtech startup working in the area of wound management and wound closure. This is also the first company from India to be leveraging the biomaterial property of silk and silk proteins to heal different types of acute and chronic wounds utilising Silk. Fibroheal has a comprehensive range of products including sheets, mesh, foams, powder, particles etc and they are already commercialised so far in the market. Fibroheal has forayed into post operative wound care and wound closure market with the launch of their new range products like “D Fibroheal Suturedress”, “D Fibroheal Scarlite” and few more using the “Fibroin” protein present in SILK. The company has a robust and strong R&D centre in Bangalore and working very closely with leading academic institutions like IISc and IITs etc and supporting a lot of students in the process while bringing down the barrier of industry – academia connects.
These products will be affordable, accessible and can heal surgical and post operative wounds much quickly compared to the existing dressings and solutions available in the market. Fibroheal products are well accepted in the market, users i.e doctors and renowned surgeons in reputed hospitals across India, and they use Silk protein derived wound management products to treat complicated wounds. Till now we have treated approx. 20000 patients with our products, across different hospitals in India.
Our products are easily accessible and affordable with 40%+ cheaper than other imported products available in the Medical devices category while being unique, innovative and patented with excellent wound healing responses.
Fibroheal Woundcare Pvt ltd was started in April 2017 by Vivek Mishra, Bharat Tandon and S Subramanian with an aspiration to create research driven comprehensive wound management company catering to different stages of wound healing including acute wounds, chronic wounds, surgical wounds, traumatic wounds etc.
The company was one of the winners of prestigious ELEVATE 100, flagship program of Karnataka government in 2019 under idea2POC program. It was followed by being winner of “Start-up of the year” in 2020 under smart bio awards during Bengaluru Tech Summit 2020. Fibroheal Woundcare Pvt Ltd was also one of the finalists of “National Start-up Awards 2020”
The company was also one of the winners of “National Technology Award 2020” organised by Technology development board, a statutory body under department of science and technology, Govt of India.
In September 2021, Fibroheal raised funding from KITVEN – KARNATAKA INFORMATION TECHNOLOGY VENTURE FUND – Venture fund arm of Karnataka Government. The company has previously raised funds from existing promoters, CCAMP (Centre for cellular and molecular platforms) and Telama Investment
Fibroheal Woundcare Pvt Ltd works across the value chain of silk growing farmers and have the potential to become an economic multiplier and it fits well with the Vision “Vocal for Local” and “Using local and taking it global”.
1) We use cut / broken cocoons which are grown by farmers and if this industry picks up, it can be an added gain for Silk growing farmers.
2) The cost of treatment will come down for patients, hospitals and home-grown innovative quality products can benefit masses.
3) Scope of employment generation is much high, and we have already demonstrated since surgeons prefer our range of products as they have seen the benefit of using our range of products derived from Silk.
More than 85% of Medical Devices are imported in India. Being the second largest producer of Silk in the world, second most populated in the world and depending solely on imports to cater to various wound healing requirements initiated the thoughts. Silk being the most versatile, perfectly biocompatible material and its abundant availability in Karnataka made it an ideal candidate for our research.
The products developed by us have a huge economic impact, can bring down imports significantly and product performance is much superior to the existing imported and marketed products, while being cost effective and affordable for patients. It lowers hospitalization costs for patients, reduces the duration of hospital stay due to faster turnaround time. Minimal dressing changes are required thus reducing nursing staff / doctors time and load on hospitals. Increases the quality and longevity of life of patients.
India is the second largest silk producing country in the world. Karnataka alone produces nearly 70% of the country`s total mulberry silk. Sericulture farming provides jobs for about 10.6 Lakh people in Karnataka directly and indirectly. More than 1.2 Lakh families in Karnataka are depending on Sericulture and mulberry cultivation. It is practised in 52,360 villages across India. But a large amount of silk is wasted in the value chain from reeling to weaving which can be utilized to develop products for biomedical use. More than 80 Lakh families are dependent directly and indirectly on silk.
We at FIBROHEAL WOUNDCARE PVT LTD always wanted to bring socio-economic multiplier effect with our innovation and work i.e from Silk growers (farmers side), surgeons (user side) and patients.
Since our facility is situated very close to Silk city of Karnataka, having largest market of silk cocoons in Asia, the sourcing of good quality silk / raw materials for our manufacturing is like at our doorstep & ease. We work on non-textile application of silk, utilizing the by-products of silk production to develop innovative, cost-effective wound healing solutions and products for patients. At the same time, we are creating employment for many, enhancing farmers income and improving the economics of silk production in India.
